Works matching IS 17569966 AND DT 2023 AND VI 4 AND IP 1
Results: 2
ACTN1 promotes HNSCC tumorigenesis and cisplatin resistance by enhancing MYH9-dependent degradation of GSK-3β and integrin β1-mediated phosphorylation of FAK.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 4, n. 1, p. 1, doi. 10.1186/s13046-023-02904-w
- By:
- Publication type:
- Article
Unveiling the role of osteosarcoma-derived secretome in premetastatic lung remodelling.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 4, n. 1, p. 1, doi. 10.1186/s13046-023-02886-9
- By:
- Publication type:
- Article